Literature DB >> 17028189

Trim5alpha accelerates degradation of cytosolic capsid associated with productive HIV-1 entry.

Udayan Chatterji1, Michael D Bobardt, Peter Gaskill, Dennis Sheeter, Howard Fox, Philippe A Gallay.   

Abstract

The TRIM5alpha (tripartite motif 5alpha protein) has been linked to the cross-species restriction in human immunodeficiency virus type 1 (HIV-1) infection of non-human cells, but the mechanism by which this occurs remains to be fully elucidated. Here we demonstrate that the capsid (CA) protein of HIV-1 is more rapidly degraded in cells expressing monkey TRIM5alpha than in cells expressing human TRIM5alpha. Other proteins encoded by Gag and Pol are not subject to TRIM5alpha-mediated accelerated degradation. The accelerated CA degradation by TRIM5alpha apparently occurs via a nonproteosomal pathway. TRIM5alpha selectively accelerates degradation of the CA population, which reached the cytosol of restrictive cells, but not the CA population, which ended into the vesicular compartment. Given that cytosolic CA represents "productively" entered cores, whereas vesicular CA represents "nonproductively" entered cores, our findings suggest that TRIM5alpha interrupts the infectious pathway of HIV-1 by acting on the incoming cytosolic CA. The mode of viral entry does not influence the accelerated degradation of cytosolic CA by TRIM5alpha. Thus, this study reveals a correlation between TRIM5alpha-mediated HIV-1 restriction and a selective degradation of cytosolic CA normally associated with productive viral entry.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028189     DOI: 10.1074/jbc.M606066200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Cellular restriction of retrovirus particle-mediated mRNA transfer.

Authors:  Melanie Galla; Axel Schambach; Greg J Towers; Christopher Baum
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

Review 2.  Host restriction factors blocking retroviral replication.

Authors:  Daniel Wolf; Stephen P Goff
Journal:  Annu Rev Genet       Date:  2008       Impact factor: 16.830

3.  Viral attachment induces rapid recruitment of an innate immune sensor (TRIM5α) to the plasma membrane.

Authors:  Seiga Ohmine; Raman Deep Singh; David L Marks; Melissa A Meyer; Richard E Pagano; Yasuhiro Ikeda
Journal:  J Innate Immun       Date:  2013-03-21       Impact factor: 7.349

4.  Rhesus monkey TRIM5α has distinct HIV-1 restriction activity among different mammalian cell lines.

Authors:  Jian Gong; Xi-Hui Shen; Hui Qiu; Chao Chen; Rong-Ge Yang
Journal:  Curr Microbiol       Date:  2011-09-24       Impact factor: 2.188

5.  Zinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradation.

Authors:  Yiping Zhu; Guifang Chen; Fengxiang Lv; Xinlu Wang; Xin Ji; Yihui Xu; Jing Sun; Li Wu; Yong-Tang Zheng; Guangxia Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

6.  Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core.

Authors:  Marisa S Briones; Charles W Dobard; Samson A Chow
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

Review 7.  HIV-1 uncoating: connection to nuclear entry and regulation by host proteins.

Authors:  Zandrea Ambrose; Christopher Aiken
Journal:  Virology       Date:  2014-02-20       Impact factor: 3.616

8.  Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species.

Authors:  Cesar A Virgen; Zerina Kratovac; Paul D Bieniasz; Theodora Hatziioannou
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

9.  Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha.

Authors:  Max W Richardson; Richard G Carroll; Matthew Stremlau; Nikolay Korokhov; Laurent M Humeau; Guido Silvestri; Joseph Sodroski; James L Riley
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

10.  Antiretroviral activity of ancestral TRIM5alpha.

Authors:  Valérie Goldschmidt; Angela Ciuffi; Millan Ortiz; David Brawand; Miguel Muñoz; Henrik Kaessmann; Amalio Telenti
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.